Our group has shown the prognostic significance of RASSF1A promoter methylation in early stage breast cancer [39] and reported the frequent RASSF1A promoter methylation in cfDNA of operable gastric cancer patients [40]. This evidence concerns the gene RASSF1 and breast carcinoma.